ArticleMammalian genome : official journal of the International Mammalian Genome Society2026
Discovery of novel alleles in Kartagener's syndrome.
Article in Mammalian genome : official journal of the International Mammalian Genome Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Kartagener's syndrome (KS) is a rare, typically autosomal recessive ciliopathy and a subtype of primary ciliary dyskinesia (PCD), characterized by situs inversus, bronchiectasis, and chronic sinusitis. KS accounts for approximately 50% of PCD cases and results from impaired motile cilia function. Defective embryonic nodal ciliary beating leads to stochastic left-right axis determination and situs abnormalities. Although numerous genes have been implicated in PCD, up to 30% of cases remain genetically unresolved, and studies specifically focused on KS cohorts remain limited. Here, we performed whole exome sequencing in 17 adult patients from a Turkish KS cohort to identify pathogenic variants and novel candidate genes. Variants were prioritised based on sequencing quality, population allele frequency, and predicted functional impact, and included single-nucleotide variants, small insertions/deletions, and copy-number variations. The restriction of the cohort to individuals with situs inversus provided a phenotype-specific context for variant interpretation, as genes not typically associated with left-right axis determination were less likely to account for disease in this study population. Pathogenic or potentially disease-associated variants were identified in multiple established PCD genes, including DNAH5, DNAI1, DNAI2, DNAAF1, DNAAF3, CFAP300, and ODAD1, with several novel alleles detected. In one patient lacking biallelic variants in known PCD genes, expanded analysis identified heterozygous variants in the cilia-associated genes DLEC1 and DNAAF9 together with a hemizygous copy number loss in EZR, a gene known to affect motile cilia function. The possible relevance of these concurrent findings warrants further investigation in genetically unresolved cases. Overall, analysis of this KS-specific cohort demonstrated a high diagnostic yield, expanded the variant spectrum associated with Kartagener's syndrome, and further supported the utility of phenotype-driven genomic analysis in genetically heterogeneous ciliopathies.
Indexed as
Identifiers
42918961What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.